# Cheng‐Hsu Chen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/cheng-hsu-chen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,044 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 29 |
| i10-index | 86 |
| Last Known Institution | FIND |
| OpenAlex ID | https://openalex.org/A5031789681 |
| ORCID iD | 0000-0002-1299-5055 |
| Works | 285 |

## Researcher papers

- [Inhibition of T–Cell Responses by Hepatic Stellate Cells Via B7–H1-Mediated T–Cell Apoptosis in Mice](https://scholariq.org/papers/inhibition-of-t-cell-responses-by-hepatic-stellate-cells-via-b7-h1-mediated-t/)
- [Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-sparsentan-versus-irbesartan-in-patients-with-iga/)
- [Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial](https://scholariq.org/papers/sparsentan-in-patients-with-iga-nephropathy-a-prespecified-interim-analysis-from/)
- [Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy](https://scholariq.org/papers/results-from-part-a-of-the-multi-center-double-blind-randomized-placebo/)
- [In vivo immune modulatory activity of hepatic stellate cells in mice](https://scholariq.org/papers/in-vivo-immune-modulatory-activity-of-hepatic-stellate-cells-in-mice/)
- [Colonic transit time in long-term dialysis patients](https://scholariq.org/papers/colonic-transit-time-in-long-term-dialysis-patients/)
- [Lower Variability of Tacrolimus Trough Concentration After Conversion From Prograf to Advagraf in Stable Kidney Transplant Recipients](https://scholariq.org/papers/lower-variability-of-tacrolimus-trough-concentration-after-conversion-from/)
- [Hypokalaemia: an independent risk factor of enterobacteriaceae peritonitis in CAPD patients](https://scholariq.org/papers/hypokalaemia-an-independent-risk-factor-of-enterobacteriaceae-peritonitis-in/)
- [High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan](https://scholariq.org/papers/high-cumulative-incidence-of-urinary-tract-transitional-cell-carcinoma-after/)
- [Risk of cancer in patients with polycystic kidney disease: a propensity-score matched analysis of a nationwide, population-based cohort study](https://scholariq.org/papers/risk-of-cancer-in-patients-with-polycystic-kidney-disease-a-propensity-score/)
- [Young-Adult Polycystic Kidney Disease is Associated with Major Cardiovascular Complications](https://scholariq.org/papers/young-adult-polycystic-kidney-disease-is-associated-with-major-cardiovascular/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)

## Researcher university

- [FIND](https://scholariq.org/institutions/find/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.